Cancer Moonshot - BloodPAC




  1. Allow approved researchers access to member contributed datasets in a scalable, reproducible, privacy and security protected manner as part of the Consortium’s collaborative effort.
  2. Access to samples while working in collaboration with the Department of Defense and Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) network.
  3. The ability to mold and influence the development of assays through a collaborative relationship with the FDA Oncology Center of Excellence, and the leadership of the Associate Director, Office of Hematology Oncology FDA and the CDRH Director.
  4. The opportunity to establish best practices and principles to incorporate into operating procedures and eliminate duplication of efforts.
  5. Foster the development and enhancement of relationships across all stakeholders in the field – pharmaceutical companies, technology companies, academic institutions, foundations, patient advocacy groups, physicians and government agencies. 

Membership Agreements

To join the BloodPAC, please review the documents below and return a signed copy of the BloodPAC Membership Agreement to info at

Exhibit A: Appendix 1

Exhibit B: Notice and License

IPR Agreements

SAmple Working Group Charter